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Mitochondrial respiratory stress (also called mitochondrial retrograde signaling) activates a Ca2/calcineurin-mediated
signal that culminates in transcription activation/repression of a large number of nuclear genes. This signal is propagated
through activation of the regulatory proteins NFB c-Rel/p50, C/EBP, CREB, and NFAT. Additionally, the heterogeneous
ribonucleoprotein A2 (hnRNPA2) functions as a coactivator in up-regulating the transcription of Cathepsin L, RyR1, and
Glut-4, the target genes of stress signaling. Activation of IGF1R, which causes a metabolic switch to glycolysis, cell
invasiveness, and resistance to apoptosis, is a phenotypic hallmark of C2C12 myoblasts subjected to mitochondrial stress.
In this study, we report that mitochondrial stress leads to increased expression, activation, and nuclear localization of
Akt1. Mitochondrial respiratory stress also activates Akt1-gene expression, which involves hnRNPA2 as a coactivator,
indicating a complex interdependency of these two factors. Using Akt1/ mouse embryonic ﬁbroblasts and Akt1
mRNA-silenced C2C12 cells, we show that Akt1-mediated phosphorylation is crucial for the activation and recruitment
of hnRNPA2 to the enhanceosome complex. Akt1 mRNA silencing in mtDNA-depleted cells resulted in reversal of the
invasive phenotype, accompanied by sensitivity to apoptotic stimuli. These results show that Akt1 is an important
regulator of the nuclear transcriptional response to mitochondrial stress.
INTRODUCTION
Mitochondria play critical roles in respiration-coupled en-
ergy production, amino acid and fatty acid metabolism,
Ca2 homeostasis, heme biosynthesis, Fe2 homeostasis,
and the integration of apoptotic signals (Babcock et al., 1997;
Kroemer et al., 1998; Loeb et al., 2005; Taylor and Turnbull,
2005). Mitochondrial dysfunction is associated with various
human diseases, from tissue-speciﬁc conditions to general-
ized whole-body disorders, including cancer (Taylor and
Turnbull, 2005). Proliferating tumors in human patients and
animal models have been shown to contain mutated or
deleted mitochondrial DNA, and/or dysfunctional mito-
chondria. Mutations in mtDNA and reduced mtDNA copy
number have been reported for numerous tumors (Horton et
al., 1996; Parrella et al., 2001; Okochi et al., 2002; Mazurek and
Eigenbrodt, 2003; Lee et al., 2004; Linnartz et al., 2004; Meier-
hofer et al., 2004; Biswas et al., 2005a; Lievre et al., 2005;
Petros et al., 2005; Taylor and Turnbull, 2005; Shidara et al.,
2005b; Kulawiec et al., 2009; Singh et al., 2009). A cybrid cell
line carrying mutations in the mtDNA-encoded ATPase 6
gene exhibited increased tumorigenicity and reduced apo-
ptosis, indicating a direct role for mtDNA mutations in
tumor progression (Petros et al., 2005; Shidara et al., 2005a).
Similarly, heteroplasmic but not homoplasmic mutations in
mtDNA encoded ND5 gene in human 143B osteosarcoma
cells were shown to be tumorigenic (Park et al., 2009). We
reported earlier that partial mtDNA depletion in C2C12
skeletal myoblasts and A549 lung carcinoma cells results in
highly invasive phenotypes that are resistant to chemically
induced apoptosis (Amuthan et al., 2002; Biswas et al.,
2005a). Induced proliferation and tumor growth promotion
by mitochondrial stress signaling in immortalized C2C12
myoblasts is of special signiﬁcance for cancer promotion
(Amuthan et al., 2001; Biswas et al., 2005a; Guha et al., 2007)
Others have shown that mtDNA depletion induces resis-
tance to apoptosis in 143B osteosarcoma (Dey and Moraes,
2000), T47D breast carcinoma (Yu et al., 2009), SK-Hep1 (Kim
et al., 2002), and prostate cancer cells (Moro et al., 2009).
Depletion of mtDNA in LNCaP androgen-dependent pros-
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3578tate carcinoma cells induces progression to androgen inde-
pendence, with increased cell migration and resistance to
common chemotherapeutic agents (Higuchi et al., 2006;
Moro et al., 2008).
Disruption of mitochondrial membrane potential—through
a reduction in mtDNA copy number, drug- and hypoxia-in-
duced mitochondrial dysfunction, or treatment with the mito-
chondrial ionophore 3-chlorophenylhydrazone (CCCP)—trig-
gers a novel stress-signaling pathway (Biswas et al., 1999;
Amuthan et al., 2001, 2002). The signaling onset is marked by
an increase in [Ca2]c and activation of Ca2-responsive cal-
cineurin (Cn) (Biswas et al., 1999; Amuthan et al., 2001, 2002).
Downstream signaling events include activation of the tran-
scription factors nuclear factor of activated T-cells (NFAT),
CAAT/enhancer binding protein  (C/EBP), cAMP-respon-
sive element binding protein (CREB), and a novel IB-depen-
dent nuclear factor B (NFB) c-Rel/p50 (Amuthan et al., 2001;
Arnould et al., 2002; Biswas et al., 2003). A recent study on the
characterization of promoter elements of stress target genes,
Cathepsin L (CnL), RyR1 (ryanodine receptor 1), and Glut 4
demonstrated the functional importance of these factor binding
sites at the 200-1000 nucleotides immediately upstream of tran-
scription start sites (Guha et al., 2009).
Heterogeneous ribonucleoprotein A2 (hnRNPA2), a nu-
clear RNA-binding protein, which is activated in response to
mitochondrial stress, was shown to function as a common
transcriptional coactivator for the up-regulation of the mi-
tochondrial stress-target genes Cathepsin L, RyR1, and
Glut-4 (Guha et al., 2009). An altered function of hnRNPA2
has been implicated in a variety of cancers including lung,
breast, and pancreatic cancers (Garayoa et al., 2003; Patry et
al., 2003; Hee et al., 2005; and Yamoka et al., 2006). hnRNPA2
protein is known to associate with a number of oncogenic
proteins including TDP-43, TOG2, and SET, although the
precise signiﬁcance of these associations in tumor progres-
sion remains unclear. A recent study from our laboratory
showed that hnRNPA2 functions as a transcription coacti-
vator by associating with the transcription complexes
mainly through protein–protein interactions (Guha et al.,
2009). The results of this study suggested that hnRNPA2
plays a key role either in the recruitment of DNA binding
factors, NFB (c-Rel/p50), C/EBP, CREB, and NFATc to
the promoter sites or in the overall stability of the enhan-
ceosome complex of mitochondrial respiratory stress-re-
sponsive genes.
Mitochondrial respiratory stress also increases cellular
glucose uptake, dependence on glucose, and glycolysis
(Guha et al., 2007) in C2C12 myoblasts, A549 cells, and RAW
264.7 macrophages. These metabolic changes are mediated
through Cn-dependent activation of insulin-like growth fac-
tor 1R (IGF1R) (Guha et al., 2007). It is now well established
that the high metabolic activity of tumor cells is associated
with activation of Akt kinase, which is downstream of
IGF1R. Akt activation in response to mitochondrial respira-
tory stress has been reported in different tumor cell systems
(Pelicano et al., 2006; Moro et al., 2009).
Here, we show up-regulation of Akt1-gene expression in
response to mitochondrial stress, along with a several-fold
increase in the level of phosphorylated Akt1 in the nuclear
compartment. We also show that Akt activation is crucial for
the full stress response, which culminates in altered expres-
sion of nuclear gene targets. We show that Akt-mediated
phosphorylation of hnRNPA2 is critical for transcriptional
modulation and cell survival under mitochondrial respira-
tory stress. Our results suggest a complex regulatory circuit
in which hnRNPA2 and Akt1 function interdependently.
MATERIALS AND METHODS
Cell Lines and Culture Conditions
Murine C2C12 skeletal myoblasts (ATCC, Manassas, VA; CRL1772) were
grown in DMEM (Life Technology, Carlsbad, CA) supplemented with 10%
fetal bovine serum and 0.1% gentamicin. Depletion of mtDNA was carried
out by ethidium bromide treatment (EtBr, 100 ng/ml for 30 passages) as
described before (Biswas et al., 1999). Selected clones containing 20%
mtDNA were grown in the presence of 1 mM sodium pyruvate and 50 g/ml
uridine. We also used 2,3-dideoxycytidine (ddC; 10 M, 120 h) in some
experiments (as mentioned) for depleting the mtDNA. Reverted cells repre-
sent mtDNA-depleted cells (85% depletion) grown subsequently for 30 cycles
in the absence of EtBr, for reversing the mtDNA content to 80% of control
cells. The mtDNA content was estimated by real-time PCR using a probe for
mouse mtDNA (D-loop) and normalized using the nuclear IB, a single-copy
gene. The sequences of the primers used are as follows: mtDNA: ACTATCCCTT-
TCCCCATTTG (forward) and TGTTGGTCATGGGCTGATTA (reverse); and nu-
clear gene IB: AGCTGGTGTCTGGGGTACAGT (forward) and ATCCTT-
GGGGAGGCATCTAC (reverse). Aliquots from the same parent stock cultures
of control, depleted, and reverted cells were used in all experiments. The relative
mtDNA content of each cell groups is shown in Figure S1.
Preparation of Nuclear and Cytosolic Protein Extracts
Nuclear and cytosolic protein fractions were isolated from different cells as
described previously (Biswas et al., 1999; Guha et al., 2007).
Immunoblot Analysis
Protein content was measured by the method of Lowry (Lowry et al., 1951).
Total cell lysates, cytosolic fractions, and nuclear fractions (30 g) were
solubilized in Laemmli’s sample buffer, resolved by electrophoresis on 10 or
12% SDS–polyacrylamide gels, and subjected to immunoblot analysis. The
immunoblots were developed using the Super Signal West Femto maximum
sensitivity substrate from Pierce Chemical Co. (Rockford, IL). Antibodies to
Akt1/2, pAkt (Ser473), and pAkt (Thr 308) were purchased from Cell Signal-
ing Technology (Beverly, MA). Antibodies to p-Serine, p-Thr, and p-Tyr were
from Sigma Chemicals (St. Louis, MO). Antibody to nuclear p97 was from
Afﬁnity Bioreagents (Golden, CO). Antibodies to DHFR (dihydrofolate reduc-
tase), -actin, and hnRNPA2 were from Santa Cruz Biotechnology (Santa
Cruz, CA).
CnA, IGF1R, and Akt1 mRNA Knockdown by Small
Interfering RNA
Predesigned small interfering RNAs (siRNAs) for mouse CnA (ID no.
292199), IGF1R (ID no. 159115), Akt1 (ID no.162426), and negative controls
(scrambled siRNA) were purchased from Ambion (Austin, TX). Control and
mtDNA-depleted cells (104 cells/well) were transfected with preannealed
double-stranded siRNAs (50 M stock) at a ﬁnal concentration of 30 nM by
the method of reverse transfection. Transient transfections were carried out in
triplicate using siPORT NeoFX reagent (Ambion). RNA was isolated 48 h after
transfections using Trizol reagent (Invitrogen, Carlsbad, CA), and the level of
silencing of CnA, IGF1R, and Akt1 mRNA was quantiﬁed by real-time PCR,
as described later in this section.
Generation of Stable hnRNPA2-silenced Cell Lines
hnRNPA2-silenced stable knockdown of C2C12 cells were described before
(Guha et al., 2009). Stable cell lines were generated after transfection (Fugene
6 reagent; Roche Molecular Biochemicals, Indianapolis, IN) of mtDNA-de-
pleted C2C12 cells with hnRNPA2si3-pSilencer2.1neo (or pSilencer2.1neo
vector alone) containing a neomycin resistance gene. HnRNPA2-silenced cell
lines were generated using G418 (1 mg/ml) as a selection marker.
Cloning and Transfections
Human Akt1 promoter (900 to 1), a kind gift from J. Q. Chen, was
subcloned into the pGL3 mammalian expression vector (Promega, Madison
WI). The c-Rel, C/EBP, NFAT, and CREB genes were cloned into the pCMV4
expression vector. hnRNPA2 cDNA was subcloned into pCI for transfections
of C2C12 cells. The WT, T98A and S219A mutant hnRNPA2 constructs in
pcDNA 3.1 () hygro plasmid were generated by Gene Pass (Nashville, TN).
Transfections were carried out using Fugene 6 reagent, following the man-
ufacturer’s suggested protocol (Guha et al., 2009). Promoter DNA constructs
cloned in the pGL3 vector (1 g) and 0.5 g of a renilla luciferase construct
(Promega) were used as an internal control. Luciferase activity was assayed
using the Dual-Luciferase reporter assay system from Promega. Transfections
with various cDNAs were carried out using 0.2 g of cDNA constructs.
mRNA Quantitation by Real-Time PCR
Total RNA was isolated using Trizol reagent as per supplier’s protocol
(Invitrogen). cDNA was generated from 5 g RNA using the cDNA Archive
kit from Applied Biosystems (Foster City, CA), and 50 ng of this cDNA was
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Akt1, and Akt2 mRNA by real-time PCR was done using SYBR Green
(Applied Biosystems) in an ABI Prism 7300 sequence detection system (Ap-
plied Biosystems). Levels of mRNA were normalized to -actin as an endog-
enous control.
Immunoprecipitation
To ensure nearly equal amounts of input Akt levels in the control and
mtDNA-depleted cell extracts, we used 100 g of protein from mtDNA-
depleted cells and 300 g protein from control cells. The nuclear and cytosolic
fractions were immunoprecipitated overnight at 4°C with hnRNPA2 antibody
(20 g/ml). The immune complexes were collected onto protein A–agarose
beads (Sigma Chemicals) and washed extensively. The immunoprecipitates
were extracted from the beads with 2 Laemmli buffer devoid of -mercap-
toethanol at 95°C for 5 min for further analysis.
Akt Activity
Akt activity was measured using an Akt/protein kinase B (PKB) kinase
activity assay kit (Stressgen Bioreagents, Victoria, BC, Canada). This assay is
based on an ELISA that utilizes a synthetic peptide as a substrate for PKB and
a polyclonal antibody that recognizes the phosphorylated form of the sub-
strate.
Annexin V Assay
The assay for cells undergoing early apoptosis was performed using the
Guava Nexin Kit (Guava Technologies, Hayward, CA) according to the
manufacturer’s suggested protocol. This method utilizes annexin V-PE to
detect phosphatidylserine on the plasma membrane as a marker of apoptotic
cells. Cells (106 each) were transfected in triplicate with Akt1 and mock
siRNAs, harvested after 48 h, washed with 1 ml 1 Nexin Buffer (Guava
Technologies), and resuspended in the same buffer. After labeling with An-
nexin V-PE, the percentage of apoptotic cells was quantiﬁed using the Guava
Personal Cytometer (Guava Technologies).
In Vitro Invasion Assay
The in vitro invasion assays were carried out as described previously
(Amuthan et al., 2001). The Matrigel invasion chambers were prepared at 1:2
dilution of Matrigel (Becton Dickinson, Belford, MA) as described previously
(Guha et al., 2007). Cells from three wells counted in a Guava Personal
Cytometer (Guava Technologies) and an equal number of viable cells (1 
105) were seeded on top of the Matrigel layer. After incubation for 24 h at
37°C, noninvading cells in the Matrigel layer were quantitatively removed,
and the microporous membrane containing invaded cells was stained and
viewed under an Olympus BX 61 ﬂuorescence microscope (Melville, NY) as
described previously (Amuthan et al., 2001; Guha et al., 2007). Each experi-
mental set was carried out in triplicate, and at least six ﬁelds were examined
within any single experiment for each condition.
In Vitro Kinase Assay
The in vitro kinase assay was carried out according to the methods of
Summers and coworkers (Summers and Birnbaum, 1997). 0.1 g of Recom-
binant Akt (Millipore, Billerica, MA) was incubated for 30 min at 37°C with
puriﬁed His-hnRNPA2 (1.0 g) in a buffer containing 10 mM HEPES (pH 7.4),
1 mM MgCl2, and 1 mM MnCl2 in the presence of 10 Ci [-32P]ATP.
Chromatin Immunoprecipitation Analysis
Chromatin immunoprecipitation (ChIP) assays were performed following the
protocol of Upstate Biotechnologies (Lake Placid, NY). Cells were ﬁxed by
adding 1% formaldehyde to the culture medium and were incubated for 10
min at 37°C. Cells were washed in 1 PBS (containing protease inhibitors),
scraped, and pelleted at 2000  g for 5 min at 4°C. The cell pellet was
suspended in SDS lysis buffer (containing 1% SDS, 10 mM EDTA, 50 mM Tris,
pH 8.1) and incubated for 10 min on ice. The cross-linked cell lysates were
sonicated using an Ultrasonic processor sonicator (10-s pulses, 20 times, on
ice), and the size of sheared DNA was checked on 0.8% agarose gel, such that
the DNA fragments were 200-1000 base pairs. The samples were centrifuged
for 10 min at 13,000  g, 4°C. The supernatant was diluted sixfold in a buffer
(pH 8.1) containing 167 mM NaCl, 16.7 mM Tris-HCl, 1.2 mM EDTA, 0.01%
Figure 1. Increased Akt1 protein and mRNA levels in
cells subjected to mitochondrial respiratory stress, ei-
ther by mtDNA depletion or treatment with CCCP. (A)
Top, immunoblot analysis of total cell lysate (30 g
protein each) from control, mtDNA-depleted C2C12
cells, and control C2C12 cells treated with CCCP (25
M, 2 h) using Akt1 antibody (1:1000 dilution). Bottom,
immunoblot analysis of total cell lysates (30 g each)
from control, mtDNA-depleted, and reverted C2C12
cells using Akt1 antibody. -Actin was used as an in-
ternal loading control. (B) Real-time PCR analysis of
mouse Akt1 and Akt2 mRNA levels in control, mtDNA-
depleted, and reverted C2C12 cells and also in control
C2C12 cells treated with CCCP (25 M, 2 h). (C) Real-
time PCR analysis of Akt1 and Akt2 mRNA in mouse
embryonic ﬁbroblasts (MEFs) treated without and with
CCCP (25 M, 2 h). (D) Immunoblot analysis of total
cell extracts (30 g each) of control and mtDNA-de-
pleted A549 lung carcinoma cells with antibody to Akt
and phospho-Ser473 Akt. (E–G) Immunoblot analysis of
nuclear extracts from H9C2 cells treated with CCCP,
mtDNA-depleted RAW 264.7 cells, and CCCP treated
MCF-7 cells with Akt and Ser437 pAkt antibodies. Al-
though not shown, mtDNA contents of A549 and
MCF-7 cells were 20–25% of control cells. In B and C,
mean  SEM values were derived from three to four
separate experiments.
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aliquot (10%) was retained as an input sample for normalization of the DNA
quantity in each sample. Each aliquot was immunoprecipitated overnight at
4°C using antibodies, as mentioned in the ﬁgure legends. Preimmune IgG was
used as a negative control. The antibody-protein complex was collected by
adding protein A–agarose/salmon sperm DNA (50% slurry; Sigma Chemi-
cals) for1ha t4°C. The protein A–agarose/antibody/protein complex was
washed to remove DNA fragments that were bound nonspeciﬁcally. DNA
was eluted from the beads, cross-linking was reversed, and after puriﬁcation
the DNA was analyzed by real-time PCR ampliﬁcation of the mouse Akt1
promoter (600 to 1). Data were normalized with the corresponding input
values.
RESULTS
Increased Expression of Akt1 in Cells Subjected to
Mitochondrial Stress
The relative levels of mtDNA and nuclear DNA in control,
mtDNA-depleted, and reverted cells are shown in Figure S1.
mtDNA content in cells treated with EtBr was reduced by
80% relative to that in control cells. We also used 2,3-
ddC to deplete mtDNA by 70% compared with control
cells (Figure S1). In reverted cells, mtDNA levels were
within 20% of control levels. Unless speciﬁed, EtBr-induced
mtDNA-depleted cells, hereafter referred to as mtDNA-de-
pleted cells, have been used in experiments reported here.
The 2,3-ddC–depleted cells are referred to as ddC mtDNA-
depleted cells.
Akt is overexpressed in tumorigenic cells (Plas and Thomp-
son, 2005); therefore we assessed Akt levels after mtDNA de-
pletion. Figure 1A (top) shows the Akt protein level in total
lysates from control, mtDNA-depleted cells, and CCCP-treated
control cells. Cells subjected to mitochondrial stress via
mtDNA depletion or CCCP treatment showed two- to three-
fold higher Akt protein relative to controls. In reverted cells,
the protein level was close to that in control cells (Figure 1A,
bottom), indicating the increase in Akt is a direct response to
mitochondrial respiratory stress.
Akt1 mRNA in C2C12 cells was increased twofold in
mtDNA-depleted and CCCP-treated cells, compared with
control cells (Figure 1B). In reverted cells, Akt1 mRNA was
reduced to a level closer to the control cells (1.5-fold above
control). The differences in the Akt2 mRNA levels between
the cell types were not signiﬁcant, indicating that Akt2 in
these cells is not regulated by mitochondrial stress.
The generality of Akt1 induction in response to mitochon-
drial stress was further investigated using nontransformed
cells (mouse embryonic ﬁbroblasts [MEF] and RAW264.7
macrophages) and transformed cells (A549 lung carcinoma,
H9C2 cardiac myoblasts, and MCF-7 breast cancer). As
shown in Figure 1C, the level of Akt1 mRNA was increased
in MEF cells in response to stress inducer, CCCP. In A549
cells (Figure 1D), H9C2 cells (Figure 1E) and RAW264.7 cells,
both the steady-state level of Akt in the total lysate and the
level of phosphorylated Akt (Ser 473) were increased in
response to mtDNA depletion or CCCP treatment. In the
case of MCF-7 cells (Figure 1G), only the level of phosphor-
ylated Akt but not the steady-state Akt increased in response
to CCCP treatment. These results show that an increase in
steady-state level of Akt under mitochondrial stress is cell
speciﬁc, although an increase in Ser-473 phosphorylation/
activation of Akt1 is a common response to mitochondrial
stress in many cell types.
Mitochondrial Stress Results in Activation and Increased
Nuclear Localization of Akt
Akt1 exists as a soluble protein in the cytosol and translo-
cates to the nucleus under growth-stimulatory conditions
(Trotman et al., 2006). As shown in Figure 2A, steady-state
Akt1 levels in the cytosol and nucleus were increased three-
fold in mtDNA-depleted cells, compared with control cells.
2,3-ddC–induced mtDNA depletion also caused nuclear
accumulation of Akt1 (Figure S1D). Akt activity was in-
creased 2.5-fold in total lysate and nuclear fractions of
mtDNA-depleted cells (Figure 2B), but was increased only
marginally in the cytosolic fraction.
Akt activation is dependent on phosphorylation by PDK1
(Ser473) and PDK2 (Thr308) (Chen et al., 2001; Kondapaka et
Figure 2. Nuclear and cytosolic levels of Akt and
phosphorylated Akt in control and mtDNA-depleted
C2C12 cells. (A) Immunoblot analysis of nuclear and
cytosolic proteins (50 g) with Akt antibody. The same
blot was reprobed with antibody to nuclear protein p97
and cytosolic protein DHFR to determine the extent of
cross-contamination and protein-loading levels. (B) Akt
activities in the total cell lysate, nuclear, and cytosolic
protein fractions were measured using a kit from Assay
Design/StressGen (Ann Arbor, MI). Phosphorylation of
a synthetic peptide substrate was assayed according to
the manufacturer’s protocol. (C) Top, immunoblot anal-
ysis of nuclear proteins (50 g protein each) from con-
trol and mtDNA-depleted C2C12 cells using antibodies
to Akt (top panel), phospho-Ser473 Akt (second panel),
phospho-Thr308 Akt (third panel). The level of phos-
phorylation was quantiﬁed by imaging the blots (n  3)
using the Bio-Rad Versa Doc Imaging system (Hercules,
CA). Mean  SEM values were calculated from three
separate assays.
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Akt activation. Nuclear extracts from control and mtDNA-
depleted cells were immunoprecipitated using Akt antibody
(Figure 2C, top), and the immunoprecipitates were probed
with phospho-speciﬁc antibodies. Ser473-speciﬁc antibody
yielded a more intense band with nuclear extract from
mtDNA-depleted cells (three- to fourfold higher), compared
with control cell extract (Figure 2C). This difference is con-
sistent with the nearly threefold increase of Akt activity in
nuclear extract from mtDNA-depleted C2C12 cells (see Fig-
ure 2B). Thr308-directed antibody yielded 50% higher in-
tensity in extract from mtDNA-depleted cells, relative to that
from control cells. The speciﬁcity of antibody-based detec-
tion of phospho-Akt was conﬁrmed using agents known to
inhibit phosphorylation of Akt at Ser473 and Thr308. ML9
markedly reduced staining with anti-Ser473 antibody, and
UCNO1 reduced the band intensity with Thr308 antibody
(Figure S2). Steady-state protein levels were not affected by
these inhibitors.
Akt1 Induction under Mitochondrial Stress Is Dependent
on Cn/IGF1 Receptor/Phosphoinositide-3 Kinase Pathway
Mitochondrial stress signaling is initiated by Cn activation,
which in turn activates IGF1 receptor downstream. We
showed previously that inhibiting IGF1R activity makes
mtDNA-depleted cells susceptible to apoptosis. We studied
the role of IGF1R in the activation of Akt1, which is known
to promote cell survival. We used siRNA-targeted silencing
of CnA and IGF1R to investigate the role of Cn/IGF1R in
Akt1 induction under mitochondrial stress (Figure 3, A–C).
Transient transfection with siRNA for CnA and IGF1R
reduced the respective mRNA levels by 60–80%, relative to
levels in mock-transfected (scrambled siRNA) cells (Figure
S3, A and B). Akt1 mRNA levels were reduced 40% by CnA
mRNA silencing in mtDNA-depleted cells, but were not
changed in control and reverted cells (Figure 3A). IGF1R
mRNA silencing caused an 80% reduction in Akt1 mRNA in
mtDNA-depleted cells and 10% reduction in reverted cells,
but no change in control cells (Figure 3B). Akt1 protein
levels were also reduced signiﬁcantly in mtDNA-depleted
cells after either CnA or IGF1R mRNA silencing (Figure
3C), but neither reduced Akt1 protein in control cells (data
not shown).
As shown for other Tyr kinase receptors, IGF1R-depen-
dent Akt activation may involve phosphoinositide-3 kinase
(PI3-K) activity. This possibility was tested by treating con-
trol and mtDNA-depleted cells with the PI3-K–speciﬁc in-
hibitor LY294002 and measuring the levels of p-Akt (phos-
pho-Ser473) in the nuclear fraction. To compare p-Akt levels,
we used equal amounts of input Akt protein from the con-
trol and mtDNA-depleted cells. LY294002 treatment re-
sulted in a signiﬁcant decrease (50%) in p-Akt levels in
control and mtDNA-depleted cells, suggesting Akt activa-
tion is a PI3-K–dependent process (Figure 3D).
Transcriptional Activation of Akt1 Promoter in Response
to Mitochondrial Stress
We next examined if the increase in Akt1 mRNA in mtDNA-
depleted cells was due to transcriptional activation of the
Akt1 promoter, using a human Akt1 promoter DNA-re-
porter construct (Park et al., 2005). Nucleotide sequence anal-
ysis (MatInspector) indicated that the 900-base pairs region
of the Akt1 gene upstream of the transcription start site
contains consensus sites for binding to the stress-activated
transcription factors NFB c-Rel, C/EBP, and CREB (Figure
4A), similar to what has been shown for other stress target
genes (Biswas et al., 2005b; Guha et al., 2009). The promoter
activity in mtDNA-depleted cells was nearly fourfold higher
than in control cells (Figure 4A). Although not shown, 5
deletion analysis revealed that this minimal promoter region
was sufﬁcient to respond to mitochondrial stress–mediated
transcription activation. Cotransfection of the promoter-re-
porter construct with c-Rel, C/EBP, and hnRNPA2 cDNAs
resulted in 2-, 3-, and 1.5-fold higher promoter driven lucif-
erase activity, respectively, over the basal activity without
cDNA transfection. As shown recently for other stress-re-
sponse genes (Guha et al., 2009), cDNA transfections in
control C2C12 cells increased promoter activity only mar-
ginally. Cotransfection with hnRNPA2 cDNA alone induced
the promoter activity by 60%. Cotransfections with
hnRNPA2 cDNA and either c-Rel or C/EBP cDNAs resulted
in a three- to fourfold increase in luciferase activity, suggesting
a cooperative interaction between these factors (Figure 4A).
Akt1 promoter activity was markedly lower in hnRNPA2-
silenced mtDNA-depleted cells (Figure 4B), conﬁrming the
role of hnRNPA2 in Akt1 transcription. This is consistent
with the reduced nuclear Akt1 protein levels found in
hnRNPA2-silenced/mtDNA-depleted cells (Figure S4). In
keeping with our observations with other stress responsive
target genes (RYR1, CnL, and Glut-4), these results suggest
that hnRNPA2 may function as a coactivator of Akt1 tran-
scriptional activity under mitochondrial stress.
The induction of stress signaling activation of Akt1 is not
restricted to EtBr-treated cells because ddC mtDNA-de-
pleted C2C12 cells also showed markedly increased nuclear
Figure 3. The role of calcineurin, IGF1R and PI3-K in the activation
of Akt1 in cells subjected to mitochondrial stress. (A) Effects of
CnA mRNA knockdown on the levels of Akt1 mRNA in control,
mtDNA-depleted, and reverted C2C12 cells. (B) Effects of IGF1R
mRNA knockdown on the levels of Akt1 mRNA in control,
mtDNA-depleted, and reverted C 2C12 cells. In both A and B, Akt1
mRNA levels were quantiﬁed using real-time PCR analysis. Mean 
SEM values were calculated from three separate estimates. (C)
Immunoblot analysis of total cell lysates (50 g each) from control,
mtDNA-depleted C2C12 cells, and control as well as depleted cells
expressing siRNAs to CnA and IGF1R were developed with Akt
antibody. A companion blot was probed with actin antibody to
assess loading levels. (D) Effects of the PI3-K inhibitor LY294002 (50
M, 2 h) on Akt and phospho-Ser473 Akt in control and mtDNA-
depleted cells. The immunoblot represents the analysis of total
lysates (50 g protein each) developed with the indicated antibod-
ies. A companion blot was probed with actin antibody to assess
protein loading.
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ally, important marker genes of stress signaling such as
RYR1, CnL, IGF1R, hnRNPA2, and Akt are also transcrip-
tionally up-regulated in ddC mtDNA-depleted cells as seen
by increase in mRNA levels by 2–3.5-fold (Figure S7B).
Increased Akt1 Promoter Occupancy of Stress-activated
Transcription Factors in mtDNA-depleted Cells
The in vivo association of stress activated transcription fac-
tors and hnRNPA2 with the Akt1 promoter DNA was in-
vestigated by ChIP analysis. The promoter occupancy of
these factors in response to mitochondrial respiratory stress
was compared in control C2C12 cells, mtDNA-depleted
cells, and mtDNA-depleted cells in which hnRNPA2 mRNA
was silenced (Figure 4C). As shown in Figure 4C, the
footprint of the mouse promoter for stress-speciﬁc factor-
binding motifs is similar to the human Akt1 promoter, in
that the proximal 600-base pair region contains sites for
binding to c-Rel, CREB, and C/EBP as in the human
Akt1 promoter, although the relative order of these fac-
tors differs for the two promoters. The mouse promoter
also contains a site for CREB immediately upstream of the
transcription start site. ChIP analysis in Figure 4 shows
that the occupancies of the Akt1 promoter by hnRNPA2,
C/EBP , c-Rel, and p50 were 10-, 30-, 7- and 6-fold higher,
respectively, in mtDNA-depleted C2C12 cells compared
with control cells. hnRNPA2 silencing in mtDNA-depleted
cells markedly reduced the levels of these factors, conﬁrm-
ing that hnRNPA2 is an adaptor protein that facilitates the
recruitment of NFB, c-Rel/p50, and C/EBP to the tran-
scription complex.
Interaction of Nuclear Akt1 and hnRNPA2 in
mtDNA-depleted Cells
We investigated the physical interaction of Akt1 with
hnRNPA2 using an antibody pulldown method, and pro-
tein species in the immunoprecipitates were identiﬁed by
nano-liquid chromatography (LC)/mass spectrometry
(MS) analysis. Figure S5A shows the gel pattern of nuclear
proteins from control, mtDNA-depleted, and mtDNA-
depleted/hnRNPA2 knockdown cells immunoprecipi-
tated by Akt1 antibody. Those protein bands that were
more abundantly pulled down from mtDNA-depleted cell
extracts compared with control and hnRNPA2 knock-
down cell extracts (Figure S5A, arrows) were subjected to
LC-MS analysis. Most of the putative Akt1-interacting
proteins identiﬁed are functionally related to cell mor-
phology, cell survival, resistance to apoptosis, and regu-
lation of oxidative stress (Table 1). Interestingly, the iden-
tiﬁcation of hnRNPA2 as a putative Akt1-interacting
protein was most relevant to this article. Notably, low or
negligible levels of hnRNPA2 were pulled down from
control and mtDNA-depleted/hnRNPA2 knockdown
cells, whereas a major population of hnRNPA2 was iden-
tiﬁed in mtDNA-depleted cells. This was conﬁrmed by
immunoblot analysis of protein pulled down by Akt1
antibody. Akt1 antibody pulled down hnRNPA2 in high
abundance from mtDNA-depleted cells, but only negligi-
ble amounts were precipitated from the control nuclear
Table 1. Nuclear proteins associated with Akt in mtDNA-depleted
cells
Proteins Molecular weight (kDa)
Thioredoxin (TRX-1) 12
Transgelin (SM22, TAGLN) 22
Myosin 120
Actin 43
14-3-3 29
Annexin A2 37
HnRNPA2 36
HnRNPK 65
Vimentin 57
Galectin 3 31
Tubulin 50
Distinctive protein bands immunoprecipitated by Akt antibody, as
shown in Supplementary Figure S5, were excised and subjected to
nano LC-MS/MS analysis.
Figure 4. Transcriptional activation of the human Akt1 promoter
by mitochondrial stress and promoter occupancy of hnRNPA2 and
other transcription factors in mtDNA-depleted C2C12 cells. (A) A
cartoon of the human Akt1 promoter, indicating the putative bind-
ing sites for stress-activated transcription factors (top). Relative
luciferase activity of the Akt1 promoter (cloned in pGL3 basic
vector) in control and mtDNA-depleted cells, cotransfected as indi-
cated with various cDNAs. (B) Promoter activity of the human Akt1
promoter in control, mtDNA-depleted and hnRNPA2-silenced/
mtDNA-depleted cells. (C) Cartoon of the mouse Akt promoter,
indicating the stress-activated factor binding sites on its proximal
region (top). ChIP analysis of the mAkt1 promoter region from
control, mtDNA-depleted, and mtDNA-depleted/hnRNPA2-si-
lenced cells. Immunoprecipitation of chromatin fragments was car-
ried out with antibodies to hnRNPA2, C/EBP, and c Rel proteins as
indicated. Real-time PCR analysis was carried out using 10% input
DNA for normalization. Values for factor binding relative to the
control cell values have been expressed. Preimmune serum was
used as a negative antibody control. Mean  SEM values were
calculated from three to four independent assays.
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mtDNA-depleted cells (Table 1; e.g., thioredoxin, transge-
lin, and galectin 3 are involved in tumorigenesis, and
some are known substrates of Akt1).
We also observed signiﬁcantly higher levels of Ser-,
Thr-, and Tyr-phosphorylation of nuclear hnRNPA2 in
mtDNA-depleted cells (Figure 5B). Sequence analysis (us-
ing www.phosphoscan.mit.edu) of hnRNPA2 (Figure 5C,
top) revealed two consensus sites for Akt phosphoryla-
tion, at Thr98 and Ser219, and four potential Tyr phos-
phorylation sites at Y123, Y264, Y275, and Y288. We fur-
ther investigated the role of Akt1 phosphorylation of
hnRNPA2 in this study. However, the role of Tyr phos-
phorylation was not investigated further.
The autoradiogram in Figure 5C of an in vitro kinase
assay using recombinant hnRNPA2 shows that hnRNPA2
is phosphorylated in vitro by Akt1 kinase. We investi-
gated the signiﬁcance of the Ser219 and Thr98 sites for
Akt1-dependent phosphorylation using bacterially expressed
and puriﬁed wild-type (WT) and mutant hnRNPA2 pro-
teins (T98A and S219A). In vitro translation (Figure S6A),
as well as the gel pattern of the puriﬁed recombinant
proteins (Figure S6B), showed no difference in either
translation efﬁciency or purity between WT, T98A, and
S219A mutant proteins. Figure 5D shows the gel proﬁles
of puriﬁed hnRNPA2 incubated with and without Akt1 in
presence of 10 Ci [-32P]ATP. Results show that phos-
phorylation is diminished by 90% in the T98A mutant
and by almost 70% in the S219A mutant, relative to WT
protein. These results suggest that both Thr98 and Ser219
are targets for Akt-mediated phosphorylation and dem-
onstrate that Akt1 phosphorylates hnRNPA2 both under
in vitro and in vivo conditions.
The functional signiﬁcance of Akt1 phosphorylation of
hnRNPA2 was further investigated by mutational analy-
sis. Previously we have shown that WT hnRNPA2 with
c-Rel or C/EBP cooperatively stimulated transcription
activation of CnL and RyR1 promoters in mtDNA de-
pleted C2C12 cells (Guha et al., 2009). In here we tested
the ability of T98A and S219A mutant hnRNPA2 cDNAs
to sustain the c-Rel or C/EBP mediated activation of CnL
promoter activity in mtDNA-depleted C2C12 cells (Figure
5E). In compliance with previous results (Guha et al.,
2009), cotransfection of CnL promoter construct with c-
Rel or C/EBP cDNAs yielded 16–20-fold higher activity
than that of the basal promoter (Figure 5E). Both T98A
and S219A mutations had a dominant negative effect be-
cause both cDNAs yielded markedly lower activities of
6–7-fold compared with the basal activity. These results
conﬁrm that Akt-mediated phosphorylation of hnRNPA2
is critical for its transcription coactivator function.
Figure 5. hnRNPA2 is a potential substrate for
Akt1-mediated phosphorylation. (A) Control
and mtDNA-depleted nuclear extracts (150 g
each) were immunoprecipitated using Akt anti-
body. Immunoprecipitates were probed with
Akt antibody (top) and hnRNPA2 antibody (bot-
tom) by immunoblot analysis. (B) Nuclear ex-
tracts from control (300 g protein) and mtDNA-
depleted (100 g protein) C2C12 cells were
immunoprecipitated using hnRNPA2 antibody,
and the immunoprecipitates were probed with
antibodies to hnRNPA2, p-Ser, p-Thr, and p-Tyr
antibodies as indicated. Note that the ﬁvefold
higher level of nuclear extract from control cells
was used to ensure nearly equal input of
hnRNPA2 protein. A companion blot was
probed with actin antibody for assessing loading
level. (C) A cartoon of hnRNPA2 indicating dif-
ferent functional domains has been presented at
the top. Putative Akt phosphorylation sites (T98,
S219) have been indicated. The bottom panel
shows the autoradiogram of phosphorylated re-
combinant puriﬁed hnRNPA2 (1.0 g), using
recombinant Akt1 (0.1 g) as described in Mate-
rials and Methods. Akt alone and hnRNPA2 alone
were used as negative controls. (D) Mutational
analysis of putative phosphorylation sites of
hnRNPA2. Autoradiogram shows the phosphor-
ylation of hnRNPA2 with (0.1 g of recombinant
Akt1) or without Akt1 or puriﬁed (1 g each)
recombinant WT, T98A, and S219A mutant
forms of hnRNPA2. (E) The functional signiﬁ-
cance of Akt phosphorylation sites (T98 and
S219) of hnRNPA2 was tested by transient trans-
fection CnL promoter in mtDNA-depleted cells.
Cells were cotransfected with or without WT
and mutant (T98A and S219A) hnRNPA2
cDNAs and c-Rel, C/EBP cDNAs as indicated.
CLP, cathepsin L promoter. Transfection condi-
tions were as described in Figure 4 and Materials
and Methods.
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of hnRNPA2
We investigated the role of Akt1 on the transcription-acti-
vator function of hnRNPA2, using ChIP analysis of CnL
promoter region in C2C12 cells expressing siRNA against
Akt1, as well as Akt1 knockout MEFs. Figure 6A shows
levels of Akt1 mRNA and protein in Akt1 knockdown/
mtDNA-depleted C2C12 cells were reduced by 55–70%,
compared with cells expressing scrambled siRNA. ChIP
analysis showed hnRNPA2 occupancy of the CnL promoter
was reduced by 75% in mtDNA-depleted cells, compared
with mock siRNA-expressing cells (Figure 6B). The mito-
chondria-speciﬁc ionophore CCCP was used to induce re-
spiratory stress in MEF cells. We showed previously that
CCCP induces Ca2- and Cn-signaling and stress-related
transcriptional activation, all of which require the action of
hnRNPA2 (Guha et al., 2009). As shown in Figure 6C, CCCP
treatment increased the hnRNPA2 occupancy of the CnL
promoter by over 100-fold. Akt1-knockout MEFs, however,
failed to respond to CCCP-mediated mitochondrial stress, as
there was no increase in the association of hnRNPA2 with
promoter DNA.
The role of Akt1 as an activator of hnRNPA2 was investi-
gated further by cotransfecting the CnL promoter construct
with various cDNAs in control and Akt1-knockout MEFs, with
or without CCCP treatment for 5 h. Treatment of control MEFs
with CCCP increased the transcriptional activity of the CnL
promoter by 2.7-fold, compared with the untreated MEF cells
(Figure 6D). Promoter activities in Akt1 knockout cells were
markedly lower than in control cells, and in the former case,
CCCP treatment had no effect on promoter activity. In control
MEF cells treated with CCCP, cotransfection with c-Rel,
C/EBP, and hnRNPA2 increased promoter activity by 4.4-,
4.0-, and 1.4-fold, respectively, over that in untreated control
cells. In Akt1 knockout cells, however, these cDNAs had min-
imal to marginal effects even after CCCP treatment. Cotrans-
fection with a combination of c-Rel plus hnRNPA2, or C/EBP
plus hnRNPA2, increased activity more than eightfold in con-
trol cells treated with CCCP, compared with untreated control
cells. Similar cotransfections in Akt1-knockout cells had no
effect on promoter activity, with or without added CCCP.
These results support the role of Akt1 in the transcriptional
activation of stress-response genes and the promoter occu-
pancy of hnRNPA2.
Figure 6. Effects of Akt1 mRNA silencing on the re-
cruitment of hnRNPA2 to CnL-promoter DNA in vivo.
(A) Top, Western blot showing Akt 1 protein levels in
mtDNA-depleted C2C12 cells expressing scrambled
siRNA (mtDNA-depleted/mock siRNA) and mtDNA-
depleted C2C12 cells expressing Akt1 siRNA (mtDNA-
depleted/Akt1siRNA). Bottom, real-time PCR analysis
of Akt1 mRNA levels in mtDNA-depleted/mock
siRNA and mtDNA-depleted/Akt1siRNA cells. (B)
ChIP analysis of CnL promoter using hnRNPA2 anti-
body in control, mtDNA-depleted/mock siRNA, and
mtDNA-depleted/Akt1 siRNA cells. Goat IgG was
used as a negative antibody control. (C) ChIP analysis
of CnL promoter using hnRNPA2 antibodies in control
and Akt1 knockout MEFs treated with and without
CCCP (25 M, 5 h). Goat IgG was used as an antibody
control. Values have been normalized to 10% of the
corresponding input values. (D) Promoter activity of
CnL promoter-reporter construct (1.0 g) in MEFs co-
transfected with different cDNAs (0.2 g) as indicated.
Values represent the mean  SEM of three separate
assays. Renilla luciferase activity was used for normal-
ization of transfection efﬁciency as described in Materi-
als and Methods.
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Phenotype and Induces Apoptosis in mtDNA-depleted
Cells
We showed previously that increased invasive behavior and
resistance to apoptosis are hallmarks of cells subjected to
mitochondrial respiratory stress in different cell types
(Amuthan et al., 2001, 2002; Biswas et al., 2005a). Because
Akt1 activation is associated with cell tumorigenicity (Se-
menza et al., 2001; Deberardinis et al., 2008), we tested the
effects of Akt1 silencing on apoptosis and in vitro invasive-
ness in mtDNA-depleted cells. Figure 7A shows the percent
apoptosis in control, mtDNA-depleted, and reverted C2C12
cells after Akt1 silencing. All three cell types contain 2–5%
apoptotic cells when Akt1 expression is unaltered (mock
siRNA). Akt1 mRNA silencing increased the apoptotic cell
population to 70% in mtDNA-depleted cells, but a much
smaller effect was seen in control and reverted cells (4–8%).
Figure 7B shows the in vitro Matrigel invasion pattern of
control, mtDNA-depleted, and reverted C2C12 cells. As re-
ported previously, mtDNA-depleted cells showed a remark-
ably higher level of invasiveness compared with control and
reverted C2C12 cells. Interestingly, Akt1 mRNA silencing
reduced the invasiveness of mtDNA-depleted cells by
85%. However, Akt1 mRNA silencing had a marginal
effect on control and reverted cells. Because equal numbers
of viable cells were used in all three cases, these results show
Akt1 plays an important role in the invasive behavior of
C2C12 cells subjected to mitochondrial respiratory stress,
possibly by regulating the activity of hnRNPA2 and, there-
fore, the transcriptional activity of stress response genes.
DISCUSSION
The Ser/Thr kinase Akt/PKB is modulated by multiple
intra- and extracellular stimuli, including hypoxia, heat
shock, oxidative stress, and cytokines (Datta et al., 1997;
Semenza et al., 2001; Lawlor and Alessi, 2001; Cho et al., 2001;
Deberardinis et al., 2008). Akt is involved in a multitude of
cellular processes, including cell survival, cell proliferation,
cancer progression, cell metabolism, RNA transport, and
transcriptional modulation (Summers and Birnbaum, 1997;
Brunet et al., 1999; Datta et al., 1999; Whiteman et al., 2002;
Hu et al., 2005; Huang and Chen, 2005; Lee et al., 2008). Akt
activation is often coupled to a change in metabolism and a
shift to increased glucose uptake and glycolysis. Recent
studies have shown that cells subjected to mitochondrial
stress develop resistance to apoptosis, which is accompanied
by a shift in cellular metabolism (Amuthan et al., 2001; Lee et
al., 2004; Meierhofer et al., 2004; Guha et al., 2007; Kulawiec
et al., 2009). The metabolic shift to glycolysis involves a
switch from insulin- to IGF1 receptor–mediated signaling in
C2C12 cells (Guha et al., 2007). We have also shown that
IGF1 receptor phosphorylation may be an autocrine process
because these cells secrete increased IGF1 (Guha et al., 2007).
Preliminary results also suggest that the activation involves
IRS1 phosphorylation. In this study, we show the metabolic
shift is accompanied by increased nuclear accumulation and
activation of Akt under mitochondrial stress.
Previous studies showed activation of Akt in mtDNA-
depleted tumor cells (Pelicano et al., 2006; Moro et al., 2009),
although the precise mechanisms of activation were not
Figure 8. Proposed mechanism of mitochondrial respiratory
stress-induced Akt1 activation and its role in transcriptional activa-
tion. (A) A model showing the main mediators of the mitochondrial
stress-signaling pathway involving calcineurin. (B) The role of Akt1
in the activation of transcription coactivator functions of hnRNPA2.
Figure 7. Akt1 mRNA silencing in mtDNA-depleted
C2C12 cells induces apoptosis and inhibits in vitro in-
vasion. (A) Annexin assay for measuring apoptosis in
control, mtDNA-depleted, and reverted cells trans-
fected transiently with mock siRNA (negative control)
or Akt1 siRNA. The graph shows the percent apoptotic
cells quantiﬁed from three independent cell cytometry
experiments. (B) Matrigel invasion assay of control,
mtDNA-depleted, and reverted C2C12 cells expressing
mock or Akt1 siRNA for 24 h.
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colon cancer cells, Pelicano et al. (2006) suggested that Akt
activation in response to mitochondrial stress may be due to
increased mitochondrial NADH accumulation and inactiva-
tion of PTEN through a redox regulated mechanism. The
nature of this redox regulation remains unclear. More re-
cently, Moro et al. (2009) showed that in mtDNA-depleted
prostate epithelial cells, Akt activation was associated with
up-regulation p85 and PI3-K. Using mRNA knockdown in
mtDNA-depleted C2C12 cells and CCCP treatment of con-
trol and Akt1 knockout MEFs, we show that Akt1 activation
is critical for the propagation of mitochondrial respiratory
stress signaling. Akt1 is activated by multiple pathways. We
show here that Akt1 activation in mtDNA-depleted or
CCCP-treated C2C12 cells is dependent on activation of Cn,
IGF1R, and PI3-K (see Figure 8A), critical hallmarks of stress
signaling. Based on our previous results on mechanism of
IGF1R activation, AMPK pathway is not likely involved in
this activation (Guha et al., 2007). Although not shown,
mitochondrial stress induced activation of Akt in A549,
H9C2, MEF, and MCF-7 cells also was dependent on IGF1R
and PI3-K activation. Here, we extend previous observa-
tions, both in terms of the mechanism of stress-induced Akt1
activation and its role in transcriptional activation of nuclear
target genes and also identify hnRNPA2 as a novel target for
Akt action.
It is well recognized that Akt mediates transcription acti-
vation directly via phosphorylation and activation of tran-
scription coactivators, such as p300 (Huang and Chen, 2005)
and Forkhead transcription factors such as Foxo3a (Brunet et
al., 1999). We show here that Akt1 phosphorylates hnRNPA2
in vitro at Thr98 and/or Ser219, and that Akt1 activity in
vivo is essential for the recruitment of the transcription
coactivator hnRNPA2 to the enhanceosome complex. This
possibility is further supported by immunoprecipitation ex-
periments showing that antibody to Akt1 pulled down
hnRNPA2 and a number of other nuclear proteins from
mtDNA-depleted cells. Negligible or undetectable precipi-
tation of this protein by Akt1 antibody from control and
reverted cell extracts suggest the Akt1-hnRNPA2 interaction
is predominately a respiratory stress-related process. Some
of the other proteins pulled down by Akt1 antibody from
mtDNA-depleted cells, such as actin, tubulin, and 14-3-3, are
known substrates for Akt1 (Vandermoere et al., 2007). At
present the functional signiﬁcance of the association of Akt1
with other proteins in Table 1 and their relevance to mito-
chondrial stress remains unclear.
Multiple techniques, including differential mRNA dis-
play, cDNA array, and proteomics, have revealed that a
wide spectrum of genes encoding mitochondrial respiratory
complex proteins, cell surface receptors, and proteins in-
volved in apoptosis, Ca2 homeostasis, and transcription
regulation are either up- or down-regulated in cells lacking
or partially depleted of mtDNA (Delsite et al., 2002; Crimi et
al., 2005; Jahangir Tafrechi et al., 2005; Biswas et al., 2008;
Johnston et al., 2009). Our results on the stress-induced ex-
pression of Akt1 mRNA in cells subjected to mitochondrial
stress by mtDNA depletion, as well as by CCCP treatment,
were surprising in view of studies showing the regulation of
human Akt1 gene expression by the Src/Stat3 pathway by
Park et al. (2005), who have shown convincingly that Stat3
response elements are localized in the exon 1-intron 1 region
of the human Akt1 gene (Park et al., 2005). It is becoming
apparent that many genes undergo multimodal regulation
under the inﬂuences of different transcription activator pro-
teins and coactivators. For example, Glut-4 expression is
known to involve cMyc and other factors (Thai et al., 1998),
whereas mitochondrial respiratory stress-induced transcrip-
tional up-regulation involves c-Rel/p50, C/EBP, CREB,
and hnRNPA2 (Guha et al., 2009). Interestingly, respiratory
stress-induced transcriptional activation of the human Akt1
promoter involves the same set of transcription factors, and
the overall location of putative DNA motifs for these factors
within the 900-base pairs region immediately upstream of
transcription initiation site resembles those of other stress
target genes (Guha et al., 2009). Notably, the footprint of
stress response elements for the human Akt1 promoter is
conserved in the mouse Akt1 gene.
Our data advances understanding of the process by which
mitochondrial respiratory stress signaling modulates the
transcription of nuclear genes. This study not only describes
the mechanism of stress-induced activation of Akt1, but also
deﬁnes its role in the phosphorylation and activation of the
transcriptional coactivator hnRNPA2. Mutational studies in
Figure 5E show that Akt1-mediated phosphorylation is crit-
ical for the hnRNPA2 mediated transcription activation of
stress target gene. Furthermore, results of ChIP analysis in
Figure 6 show that Akt function is critical for the recruitment
or association of hnRNPA2 to the enhanceosome complex.
Importantly, the activation of Akt1 in response to mitochon-
drial respiratory stress involves the same four signature
factors (C/EBP, c-Rel/p50, NFAT, and CREB) and recruit-
ment of hnRNPA2. Previously we have shown that different
domains of hnRNPA2 may be involved in the binding or
recruitment of different transcription factors (Guha et al.,
2009). In view of this mutational analysis, in this study
showing the importance of the Akt target sites of hnRNPA2
(T98 and S219) suggests that these two phosphorylation sites
may be important for recruiting different transcription fac-
tors. The observed 60–70% reduction in activity with either
T98A or S219A mutant hnRNPA2 is consistent with our
proposed model on the cooperativity between the signature
factors (c-Rel/p50, C/EBP, CREB and NFAT) in the activa-
tion of stress target genes (Guha et al., 2009 and Figure 8).
An intriguing observation is the self-regulatory role of Akt1,
in that transcriptional activation of this gene requires Akt1-
mediated phosphorylation of hnRNPA2. The general mecha-
nism of stress-induced transcription activation is presented as
a model in Figure 8B. We believe the mechanism described
here is important in understanding the cellular response to
altered mitochondrial function and bioenergetics.
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